Other Income & Expense
Other Income (Expense)
West Pharmaceutical Services Other Income (Expense) increased by 50.0% to -$200.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from -$200.00K to -$200.00K. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a -35.9% CAGR.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryProfitability
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Detailed definition
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Peer comparison
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
Metric ID:
other_income_expense_netHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$300.00K | -$300.00K | $5.10M | -$1.90M | -$1.20M | -$50.00M | $0.00 | $2.60M | $2.40M | $9.70M | $4.60M | $2.50M | $3.20M | -$11.30M | -$200.00K | -$200.00K | -$200.00K | -$400.00K | -$200.00K |
| QoQ Change | — | +0.0% | >999% | -137.3% | +36.8% | <-999% | +100.0% | — | -7.7% | +304.2% | -52.6% | -45.7% | +28.0% | -453.1% | +98.2% | +0.0% | +0.0% | -100.0% | +50.0% |
| YoY Change | — | — | — | — | -300.0% | <-999% | -100.0% | +236.8% | +300.0% | +119.4% | +76.9% | +4.2% | -67.0% | — | -104.3% | -108.0% | -106.3% | +96.5% | +0.0% |
Range-$50.00M – $9.70M
CAGR-8.6%
Avg YoY Growth<-999%
Median YoY Growth-33.5%
Other Income (Expense) at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's other income (expense)?
- West Pharmaceutical Services (WST) reported other income (expense) of -$200.00K in Q1 2026.
- How has West Pharmaceutical Services's other income (expense) changed year-over-year?
- West Pharmaceutical Services's other income (expense) decreased by 0.0% year-over-year, from -$200.00K to -$200.00K.
- What is the long-term trend for West Pharmaceutical Services's other income (expense)?
- Over 3 years (2021 to 2025), West Pharmaceutical Services's other income (expense) has grown at a -35.9% compound annual growth rate (CAGR), from $3.80M to -$1.00M.
- What does other income (expense) mean?
- The net result of all income and expenses not related to core business operations.